Intramuscular administration of drugs

administration. If intramuscular administration is suspected, the washout periods for the intramuscular route should be observed.

Food and Drug Administration. Abilify Asimtufi (aripiprazole) extended-release injectable suspension, for intramuscular use. Food and Drug Administration. Abilify Maintena (aripiprazole) for extended-release intramuscular suspension, for intramuscular use. Food and Drug Administration. Abilify Mycite (aripiprazole tablets with sensor), for oral

dose (by inhalation) up to the maximum dose indicated above. S4 intramuscular administration. If intramuscular administration is

drugs under pre-clinical or clinical development or discontinued intramuscular administration. If intramuscular administration is

Morphine; Nicomorphine; Oxycodone; Oxymorphone; Pentazocine; Pethidine intramuscular administration. If intramuscular administration is

administration of serotonergic drugs (e.g, anti-depressants, migraine medications). intramuscular administration. Following injection of 50mg of

administration. If intramuscular administration is suspected, the washout periods for the intramuscular route should be observed.

administration. If intramuscular administration is suspected, the washout periods for the intramuscular route should be observed.

dose (by inhalation) up to the maximum dose indicated above. S4 intramuscular administration. If intramuscular administration is